These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 15366329

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Reduction of the number and severity of respiratory tract infections in children by oral immunostimulation.
    Riedl-Seifert RJ, van Aubel A, Kämmereit A, Elsasser U.
    Adv Exp Med Biol; 1995; 371B():799-802. PubMed ID: 7502900
    [No Abstract] [Full Text] [Related]

  • 3. Diversity of mucosal immune responses in upper respiratory organs and its application for mucosal vaccine.
    Kurono Y, Miyashita K, Makise T, Nagano H.
    Adv Otorhinolaryngol; 2011; 72():146-8. PubMed ID: 21865715
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Problems and progress towards vaccination against bacterial infections of the respiratory tract.
    Artenstein MS.
    Dev Biol Stand; 1975; 28():115-25. PubMed ID: 236208
    [Abstract] [Full Text] [Related]

  • 9. Intranasal vaccines for protection against respiratory and systemic bacterial infections.
    Oliveira ML, Arêas AP, Ho PL.
    Expert Rev Vaccines; 2007 Jun; 6(3):419-29. PubMed ID: 17542756
    [Abstract] [Full Text] [Related]

  • 10. Edible vaccines tackle mucosal infections head on.
    Bonn D.
    Lancet Infect Dis; 2002 May; 2(5):263. PubMed ID: 12062981
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Rationale for the clinical use of a ribosome-component immune modulator.
    Pregliasco F, Terracciano L, Marcassa S, Zava D, Anselmi G.
    Allergy Asthma Proc; 2009 May; 30 Suppl 1():S5-12. PubMed ID: 19679000
    [Abstract] [Full Text] [Related]

  • 14. [Nasal vaccines].
    Kido H, Mizuno D, Takei T.
    Nihon Rinsho; 2008 Oct; 66(10):1881-7. PubMed ID: 18939485
    [Abstract] [Full Text] [Related]

  • 15. [Prospects of use coryneformic bacteria drug to prevent and treat respiratory infections].
    Shmeleva EA, Vartanian RV, Aleshkin VA, Paramonova IuA, Baturina iG, Malyshev NA.
    Vestn Ross Akad Med Nauk; 2008 Oct; (3):12-6. PubMed ID: 18421903
    [Abstract] [Full Text] [Related]

  • 16. Prevention of bacterial respiratory infection by a new vaccine, an association of bacterial ribosomes and membranous adjuvants. 1. General remarks.
    Michel FB, Dussourd d'Hinterland L.
    Arzneimittelforschung; 1980 Oct; 30(1a):196-8. PubMed ID: 6892779
    [No Abstract] [Full Text] [Related]

  • 17. Ribosomal immunotherapy for recurrent respiratory tract infections in children.
    Béné MC, Faure GC.
    Paediatr Drugs; 2003 Oct; 5(4):223-8. PubMed ID: 12662118
    [Abstract] [Full Text] [Related]

  • 18. Mucosal immunization using recombinant plant-based oral vaccines.
    Streatfield SJ.
    Methods; 2006 Feb; 38(2):150-7. PubMed ID: 16431131
    [Abstract] [Full Text] [Related]

  • 19. Bacterial vaccines and the innate immune system: a journey of rediscovery for the allergist-immunologist and all health care providers.
    Bellanti JA, Settipane RA.
    Allergy Asthma Proc; 2009 Feb; 30 Suppl 1():S3-4. PubMed ID: 19678999
    [No Abstract] [Full Text] [Related]

  • 20. Vaccination programs for bovine respiratory diseases.
    Kahrs RF.
    Mod Vet Pract; 1976 Jan; 57(1):29-32. PubMed ID: 173981
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.